Celik Turgay, Iyisoy Atila, Yuksel U Cagdas, Isik Ersoy
Int J Cardiol. 2008 Aug 29;128(3):432-3. doi: 10.1016/j.ijcard.2007.05.044. Epub 2007 Aug 8.
In the light of current data obtained from prospective outcome studies, we believe that it is premature to support the use of homocysteine-lowering vitamins including folic acid in patients with established coronary artery disease in order to improve cardiovascular outcomes. We think that future large-scale epidemiological trials with very long-term follow-up periods will probably solve this dilemma.
